Background {#Sec1}
==========

The filamentous fungus *Aspergillus niger* is widely known for its secretion capacity of metabolites, proteins and enzymes. Due to the species robust nature, and range of interesting compounds with generally regarded as safe (GRAS) status that it can produce, *A. niger* is a frequently used work-horse in industrial biotechnology \[[@CR1]\]. Notable examples of industrial compounds produced by *A. niger* are citric acid, oxalic acid, gluconic acid, amylase and glucoamylase \[[@CR2]--[@CR5]\]. *A. niger* has also been proposed for the production of heterologous products, such as cyclodepsipeptides, a class of secondary metabolites that exhibit a variety of pharmaceutically relevant bioactivities and itaconic acid (IA), a promising sustainable chemical building-block for the fabrication of various synthetic resins, coatings, and polymers \[[@CR6], [@CR7]\].

The production of IA with *A. niger* reaches industrially relevant titers due to an rewired pathway involving the endogenous cytosolic citrate synthase CitB and ATP-citrate lyase \[[@CR8], [@CR9]\]. Together with an improved fermentation protocol this resulted in the highest IA titer reported for *A. niger* (56.5 g/l) \[[@CR9]\]. However, this metabolic rewiring towards IA proved more intricate as we have also observed induction of genes that are responsible for IA bioconversion and degradation in high IA producing *A. niger* strains \[[@CR10]\]. The gene products itaconyl-CoA transferase (IctA) and itaconyl-CoA hydratase (IchA) together constitute a pathway that bears much similarity with IA degrading pathways reported in *A. terreus* and the pathogenic bacteria *Pseudomonas aeruginosa* and *Yersinia pestis* \[[@CR11], [@CR12]\]. However, whereas the IA degrading pathways in aforementioned species convert IA into the cellular building-blocks pyruvate and acetyl-CoA, the end product of the pathway in *A. niger* is unknown, as the gene encoding the enzyme that facilitates the final step in the conversion of citramalyl-CoA into pyruvate and acetyl-CoA, *cclA*, although present, is not induced in *A. niger* under IA degrading conditions. We have previously reported that an unknown peak was detected during HPLC analysis in samples where extracellular IA titers were diminishing \[[@CR10]\] Deletion of the pathway specific genes *ictA* and *ichA* results in cessation of IA bioconversion and concomitantly the unknown peak is also no longer detected \[[@CR10]\]. In this study, we have focused on identifying the gene pathways related to this unknown compound, identified as citramalate (CM), and its link with IA production in *A. niger*. To further explore the unexpected level of metabolic rewiring in IA producing *A. niger* strains, we have analyzed the transcriptome of high and low IA producing strains for genes that are related to biosynthesis and transport of the industrially relevant metabolites citric acid, succinic acid, fumaric acid, malic acid, lactic acid, gluconic acid, oxalic acid, itaconic acid and citraconic acid to see the effects on these genes, which interestingly have led to the identification of another completely unknown CM biosynthesis route \[[@CR13]\].

Materials and methods {#Sec2}
=====================

Strains and culture conditions {#Sec3}
------------------------------

All *A. niger* strains used in this study are listed in Table [1](#Tab1){ref-type="table"}. All strains are maintained on minimal medium (MM) plates (10 g/l glucose, 16 g/l agar, 6 g/l NaNO~3~, 0.52 g/l KCl, 1.52 g/l KH~2~PO~4~, 0.0022 g/l ZnSO~4~ × 7H~2~O, 0.0011 g/l H~3~BO~3~, 0.0005 g/l MnCl~2~ × 4H~2~O, 0.0005 g/l FeSO~4~ × 7H~2~O, 0.00017 g/l CoCl~2~ × 6H~2~O, 0.00016 g/l CuSO~4~ × 5H~2~O, 0.00015 g/l NaMoO~4~ × 2H~2~O, 0.005 g/l Na~2~EDTA and 0.5 g/l Mg~2~SO~4~), or liquid complete medium (LCM) (MM + 2.5 g/l yeast extract). The medium was supplemented with 2.44 g/l uridine and 1.12 g/l uracil (UU) when required. Typically, plates were incubated at 35 °C, MTPs were incubated at 33 °C, and shake flasks were incubated at 35 °C. Spore suspensions were prepared by harvesting spores from MM plates after 3--5 days incubation at 35 °C using physiological salt solution (0.9% NaCl) and subsequent filtering of the solution through Miracloth (EMD Millipore). For long term storage strains were stored in 20% glycerol at − 80 °C.Table 1Strains used in this studyStrainAbbreviationDescriptionAB1.13AB1.13 WTUridine auxotroph \[[@CR14]\]AB1.13 *pyrG*+AB1.13Uridine prototroph of AB1.13 \[[@CR15]\]AB1.13 CAD 4.1AB1.13 CADSelected pyrG+ transformant of *cadA* expressing transformant (CAD10.1) of AB1.13 \[[@CR16]\]AB1.13 CAD + MFS + MTT \#49B;AB1.13 \#49BSelected *mttA* expressing transformants of AB1.13 CAD + MFS 3.9 \[[@CR8]\]AB1.13 CAD + MFS + MTT + CitB \#99CitB\#99Selected *citB* overexpressing strain of AB1.13 CAD + MFS + MTT \#49B \[[@CR8]\]AB1.13 cimA A10AB1.13 cimA B3AB1.13 cimA D11CimA A10CimA B3CimA D11Selected *cimA* overexpressing strain of AB1.13 (this study)AB1.13 cimA B3 pyrE−CimA B3 pyrE−*pyrE* mutant strain of CimA \#B3 (this study)AB1.13 cimA B3 + mfsB 27CimA + MfsB \#27Selected *mfsB* overexpressing strain of AB1.13 cimA B3 pyrE− (this study)AB1.13 cimA B3 + mfsB 28CimA + MfsB \#28

Auxotrophic mutant (*pyrE*) selection {#Sec4}
-------------------------------------

CimA \#B3 was cultivated on MM agar plates in the presence of 5-Fluoroorotic acid (5-FOA) to generate *pyrE* mutant strains, resulting in uridine auxotrophy. Spores of colonies were transferred to MM + 5-FOA agar supplemented with uridine and uracil in 48 well plates, using sterilized toothpicks, for an additional selection round. Growing strains of the second selection round were transferred to MM without uridine and uracil to check if the 5-FOA resistant mutants were indeed uridine auxotroph. DNA was isolated from uridine auxotrophic transformants, as described in "[Vector construction and transformation](#Sec5){ref-type="sec"}", and PCR with primers 98 + 99 (Additional file [1](#MOESM1){ref-type="media"}: Table S1) was performed to confirm *pyrE* mutant strains.

Vector construction and transformation {#Sec5}
--------------------------------------

Restriction digestion, ligation and other standard molecular biological techniques were performed using common procedures \[[@CR17]\]. All primers were obtained from Eurogentec and are listed in Additional file [1](#MOESM1){ref-type="media"}: Table S1. PCR reactions were performed with the Alpha Cycler 4 (PCRmax). All enzymes were purchased from ThermoFisher and used following the manufacturer's protocols. Fungal DNA isolations for colony PCR were performed on mycelia grown in 1 ml LCM in a 2 ml round well 96-well microtiter plate (MTP) (Axygen) sealed with semi permeable film at 33 °C, 850 rpm, overnight in a rotary shaker. DNA was isolated from the mycelia using the DNA isolation from Plant kit and protocol (Nexttec GmbH). This included homogenization with 300 μl acid washed 0.1 mm Zirconium beads (Biospec Products) and 2 × 1 min bead-beating with cooling on ice in between (Mini-Beadbeater-96). The supernatant was directly used as template for PCR.

To create overexpression construct of *cimA* the An09g00170 gene was in vitro synthesized at GeneArt (Waltham, MA) and subsequently digested with HindIII. The digested *cimA* fragment was ligated in HindIII digested pAB*gpdI* vector containing the *A. niger gpdA* expression signals, thereby establishing the pABgpdI-cimA expression vector.

For the construction of an *mfsB* (An09g00190) expression vector, *mfsB* was PCR amplified from AB1.13 genomic DNA with Phusion HF Master Mix and primer pair 432 + 433 (Additional file [1](#MOESM1){ref-type="media"}: Table S1) following standard protocols. The resulting fragment was purified, using the QIAquick PCR purification kit and protocol (Qiagen). 2.5 μg of the purified fragment was digested with NcoI/BpiI in one reaction, and BpiI/BglII in a second reaction. The 1123 bp generated fragment from the first reaction and 623 bp generated fragment from the second reaction were excised from gel and purified using the QIAquick gel extraction kit and protocol (Qiagen). These two fragments were inserted into an NcoI/BglII opened pAB-gpdI backbone carrying the *gpdA* expression signals, originating from pABgpdI-citC \[[@CR10]\], establishing the *mfsB* expression vector pABgpdI-mfsB. This was done in a ligation reaction consisting of T4 DNA ligase and buffer, and a total of 140 μg DNA with a vector:insert ratio of 1:3. The mixture was incubated at room temperature for 30 min. 4 μl of the ligation mixture was transformed into *Escherichia coli* JM109 (Promega) according to the manufacturer's standard heat shock protocol. Presence of pABgpdI-mfsB in colonies was checked with colony PCR, using DreamTaq Green PCR Master Mix. Several positive transformants were miniprepped according to the GeneJET Plasmid Miniprep kit and protocol (ThermoFisher). Restriction analysis with BpiI was performed to validate the plasmids identity, followed by maxiprep of designated transformants using the Plasmid Plus Maxi kit and protocol (Qiagen). The identity of the purified plasmid was verified by Sanger sequencing using primers 143, 329, 430 and 431 (Additional file [1](#MOESM1){ref-type="media"}: Table S1) (Baseclear).

For transformation of *A. niger*, linear DNA fragments were used. The linear DNA fragment PgpdA-cimA-TgpdA and PgpdA-mfsB-TgpdA was obtained through PCR amplification with Phusion HF Master Mix, and primers 80 + 81 (Additional file [1](#MOESM1){ref-type="media"}: Table S1). These PCR fragments were co-transformed with linear fragments of PpyrE-pyrE-TpyrE (2.7 kb) (for *mfsB* overexpression) and with pAB4-1, that harbours the *A. niger pyrG* gene for (*cimA* overexpression) \[[@CR18]\], in an ratio of 1:10 (0.5 µg marker:5 µg construct).

Transformants were plated on MM + 1.2 M sorbitol as osmotic agent and selected based on the reestablishment of uracil prototrophy due to integration of the functional *pyr* expression cassette. Individual colonies were transferred to 48-well plates containing MM agar. These were used to inoculate MTPs, and DNA was isolated as described earlier. Successful integration of the *mfsB* and *cimA* expression cassettes was determined by colony PCR, using primers 143 + 433 for PgpdA-mfsB-TgpdA and 143 + 331 for PgpdA-cimA-TgpdA. Positive transformants were streaked on MM plates to obtain pure colonies. DNA isolation and colony PCR was repeated as described above, and positive transformants were used to prepare spore suspensions as described in "[Strains and culture conditions](#Sec3){ref-type="sec"}".

Shake flask cultivations {#Sec6}
------------------------

Shake flask production tests were performed in 300 ml non-baffled shake flasks containing 60 ml or 500 ml non-baffled shake flasks containing 100 ml M12++ medium (1.43 g/l NH~4~NO~3~, 0.11 g/l KH~2~PO~4~, 0.5 g/l MgSO~4~ × 7H~2~O, 0.005 g/l CuSO~4~ × 5H~2~O, 0.0006 g/l FeCl~3~ × 6H~2~O, 0.0006 g/l ZnSO~4~ × 7H~2~O, 0.074 g/l NaCl, 0.13 g/l CaCl~2~ × 2H~2~O and 100 g/l glucose, adapted from Li et al. \[[@CR16]\]). Shake flasks were inoculated with 1 × 10^6^ spores/ml medium and incubated at 35 °C, 250 rpm for up to 2 weeks. 350 μl samples were taken daily, filtered and used to determine extracellular metabolite concentrations by HPLC as described in section "[Metabolite analysis](#Sec7){ref-type="sec"}". Flasks were weighed before sampling to correct metabolite concentrations for medium evaporation.

Metabolite analysis {#Sec7}
-------------------

Extracellular metabolite concentrations were determined by high-performance liquid chromatography (HPLC). A WATERS e2695 separations module equipped with an Aminex HPX-87H column (Bio-Rad) was used in combination with 5 mM H~2~SO~4~ as eluent, coupled to a refractive index detector (WATERS 2414) and a dual-wavelength detector (WATERS UV/Vis 2489) for peak detection. For identification of various organic acids as described in fungal biosynthetic pathways, reference compounds were analyzed for retention time and UV210~nm~/RI area ratios. Empower PDA software was used for data processing.

RNA isolation, transcriptome sequencing and analysis {#Sec8}
----------------------------------------------------

Biomass samples for RNA isolation were taken at several timepoints during controlled-batch cultivation and washed with distilled water and frozen in liquid N~2~. The controlled batch cultivations were performed using 5 l scale benchtop New Brunswick Scientific fermenters (BioFlo 3000) at 33 °C. Starting pH was 3.5 after inoculation and M12 medium \[[@CR16]\] was allowed to naturally acidify till pH 2.3 and then kept at pH 2.3 by addition of 4 M KOH. Dissolved oxygen (DO) tension was 25% at the moment of inoculation and when DO dropped till 20% it was kept at 20%. The system was calibrated with 100% sterile air as 100% DO and 100% N~2~ as 0% DO. The fermenter was inoculated by 72 h old 100 ml non-baffled shake flask cultures containing 1.0\*10^8^ spores. mRNA isolation procedures for transcriptome sequencing and analysis are published in Hossain et al. \[[@CR10]\].

Results {#Sec9}
=======

IA bioconversion in *A. niger* revisited {#Sec10}
----------------------------------------

In our previous communication, we have reported the role of *ictA* and *ichA* during IA bioconversion in *A. niger* \[[@CR10]\]. We have observed that the expression of *ictA* and *ichA* is induced under IA producing conditions in high IA producing strain CitB\#99 and knock-out of these genes resulted in abolishment of IA bioconversion \[[@CR10]\]. Surprisingly, during IA bioconversion, we have also observed the occurrence of an previously unidentified compound in HPLC analysis (Fig. [1](#Fig1){ref-type="fig"}). Upon further analysis we hypothesized that this unidentified peak could be citramalic acid (CM), as based on the identified IA bioconversion pathway, citramalyl-CoA is an intermediate that is formed during IA bioconversion, which could be converted to CM by action of IctA \[[@CR10], [@CR11]\]. To confirm this, detailed HPLC analysis was carried out. Based on this analysis, the unidentified compound shared a very similar retention time and UV210~nm~/RI area ratio, as the CM standard (Additional file [1](#MOESM1){ref-type="media"}: Tables S2 and S3). Based on this observation we concluded that the unidentified peak is CM.Fig. 1Unidentified peak next to the glucose peak on RI detector in sample after 14 days cultivation of CitB\#99 performed in 500 ml non-baffled flasks \[[@CR10]\]

Upon this observation, we have revisited our previous fermentation data as presented in Hossain et al. \[[@CR8], [@CR10]\] to identify the presence of CM during conditions of IA bioconversion (Fig. [2](#Fig2){ref-type="fig"}). Interestingly, in both cases we have been able to identify the presence of CM in the extracellular medium upon decreasing levels of IA in the medium. The occurrence of CM in both cases coincides with reducing titers of IA, further strengthening the hypothesis that IA is converted into CM in *A. niger* (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Previous fermentation data revisited. **a** Controlled batch-cultivation of CitB\#99 in 5 l bioreactors \[[@CR8]\]. CM can be detected after 180 h EFT when IA titers start to diminish. **b** Non-shaking 500 ml flask cultivation \[[@CR10]\]. CM detected in cultivations with CitB\#99 after 264 h EFT when IA titer starts to drop. No CM detected in cultivations with CitB\#99 ΔICT and CitB\#99 ΔICH

Alternative organic acid production in *A. niger* {#Sec11}
-------------------------------------------------

It is well established in literature that *A. niger* is a prolific producer of organic acids, more particular gluconic, citric and oxalic acid \[[@CR19]\]. The unexpected finding of CM biosynthesis and secretion during IA bioconversion prompted us to search for additional and previously unidentified organic acid biosynthesis pathways in this organism. For this purpose we have explored the genome mining efforts presented by Li et al. \[[@CR13]\] in *A. niger* to identify genes potentially related to the biosynthesis of nine industrially relevant organic acids: citric acid, succinic acid, fumaric acid, malic acid, lactic acid, gluconic acid, oxalic acid, itaconic acid and citraconic acid. In Table [2](#Tab2){ref-type="table"} we have summarized transcriptome data of these genes. Furthermore, transcriptome data of the putative orthologs and paralogs in *A. niger* of the well described transporters for malic acid (MaeA) \[[@CR20]\], itaconic acid (Itp1 and MfsA) \[[@CR8], [@CR21], [@CR22]\] and hydroxyparaconic acid (Itp1) \[[@CR22]\] are presented together with the citrate exporter CexA \[[@CR23]\] (Table [3](#Tab3){ref-type="table"}). From this latter comparison it is interesting to note that the two functionally characterized IA transporters have different putative orthologs in *A. niger* (Table [3](#Tab3){ref-type="table"}), which by itself is a IA non-producing strain.Table 2Transcriptome data of genes involved in the biosynthesis of industrially relevant organic acidsNew locus tagOld locus tagGene productGene nameLocalizationRPKM valuesAB1.13AB1.13 CADAB1.13 \#49BCitB\#991ANI_1\_1206064An07g09530Pyruvate dehydrogenase E1 component subunit alphaMito319.96296.42259.17203.011ANI_1\_622094An11g04550Pyruvate dehydrogenase E1 component subunit alphaMito18.2116.8923.0927.181ANI_1\_12014An01g00100Pyruvate dehydrogenase E1 component subunit betaMito204.86158.00136.09125.152ANI_1\_274064An07g02180Pyruvate dehydrogenase E2 componentMito232.08210.10209.07225.043ANI_1\_440184An04g02090Pyruvate carboxylase*pycA*Cyto306.10262.83309.14395.414ANI_1\_876084An09g06680Citrate synthase*citA*Mito284.82269.02255.71238.094ANI_1\_1474074An08g10920Citrate synthase*citB*Cyto3.053.102.8710838.654ANI_1\_2950014An01g09940Citrate synthase*citC*Cyto463.10370.88438.0896.445ANI_1\_470084An09g03870Aconitate hydrataseMito56.6537.1545.1250.785ANI_1\_3018024An02g11040Aconitate hydrataseCyto0.040.040.000.005ANI_1\_1410074An08g10530Aconitate hydratase*acoA*Mito326.50284.14426.11486.325ANI_1\_1808144An16g05760Aconitate hydrataseCyto1.301.131.032.025ANI_1\_578044An05g02230Aconitate hydrataseCyto2.917.346.2011.045ANI_1\_1802134An15g07730Aconitate hydrataseCyto28.7543.7946.1127.816ANI_1\_906164An18g06760Isocitrate dehydrogenase (NAD+) subunit 1Mito189.71209.47167.93190.846ANI_1\_798074An08g05580Isocitrate dehydrogenase \[NAD\] subunit 2Mito165.29175.80165.81151.756ANI_1\_3136024An02g12430Isocitrate dehydrogenase \[NADP\]Per53.9350.4643.2264.477ANI_1\_826184An04g047502-Oxoglutarate dehydrogenaseMito115.53103.38107.2788.878ANI_1\_1482094An11g11280Dihydrolipoyllysine-residue succinyltransferaseMito168.01172.17158.22198.859ANI_1\_230154An17g01670Succinyl-CoA ligase \[GDP-forming\] subunit alphaMito264.96249.57263.12194.379ANI_1\_58124An14g00310Succinyl-CoA ligase \[GDP-forming\] subunit betaMito277.86256.78249.99212.8110ANI_1\_1750024An02g12770Succinate dehydrogenase \[ubiquinone\] flavoprotein subunitMito245.43193.93185.80107.8110ANI_1\_2706024An02g07600Succinate dehydrogenase \[ubiquinone\] flavoprotein subunitMito0.470.350.790.9511ANI_1\_952104An12g07850Fumarate hydrataseMito121.25107.39124.39128.6712ANI_1\_12134An15g00070Malate dehydrogenase*mdhA*Cyto402.08426.49462.06636.3712ANI_1\_268064An07g02160Malate dehydrogenaseMito500.20510.92572.33565.4712ANI_1\_2230094An11g07190Malate dehydrogenaseCyto0.140.150.000.1513ANI_1\_1256014An01g09270Isocitrate lyase*acuD*Per86.3861.7765.2042.2613ANI_1\_1336134An15g02980Isocitrate lyase/malate synthasePer33.7634.7525.0322.6613ANI_1\_1826104An12g05180Isocitrate lyase/malate synthaseCyto0.000.090.000.4814ANI_1\_320134An15g01860Malate synthasePer112.4198.3472.3334.3815ANI_1\_2114184An04g08220[l]{.smallcaps}-Lactate dehydrogenaseMito/Cyto0.090.580.510.6316ANI_1\_1536084An09g06220PrpD-like proteinCyto0.300.230.360.4316ANI_1\_2952014An01g09950PrpD-like proteinCyto552.06456.98383.21165.4116ANI_1\_2948014An01g09930PrpD-like proteinMito308.68261.08288.92145.6616ANI_1\_3352024An02g14730PrpD-like proteinCyto5.977.295.8110.0817ANI_1\_1432064An07g00760Itaconyl-CoA transferase*ictA*Mito13.07108.35170.34375.8918ANI_1\_2118064An07g09220Itaconyl-CoA hydratase*ichA*Mito7.3260.28146.61232.6519ANI_1\_1156014An01g08610Citramalate-CoA lyase*cclA*Mito10.1712.5921.4319.5420ANI_1\_92174An10g00820Oxaloacetate acetylhydrolase*oahA*Cyto1803.481122.69323.449.8120ANI_1\_2054064An07g08390Oxaloacetate acetylhydrolaseMito10.417.317.5511.7021ANI_1\_1678104An12g03440Glucose oxidaseSecreted0.660.840.210.2321ANI_1\_748094An11g05580Glucose oxidaseSecreted1.011.801.150.1921ANI_1\_1398064An07g00450Glucose oxidaseSecreted1.470.670.381.4521ANI_1\_1992014An01g14740Glucose oxidase*goxC*Secreted1.250.700.560.2022ANI_1\_106174An10g00900GluconolactonaseCyto1.372.051.643.3022ANI_1\_254044An05g02030GluconolactonaseCyto/Nucleus1.751.791.912.9822ANI_1\_1902144An16g06620GluconolactonaseSecreted0.000.000.000.0023ANI_1\_928084An09g001702-Isopropylmalate synthase*cimA*Cyto362.80298.38108.9223.5224ANI_1\_440024An02g03250Isopropylmalate isomeraseCyto135.2057.7045.9696.62RPKM values, taken from Hossain et al. \[[@CR10]\] were calculated according to the method presented by Mortazavi et al. \[[@CR28]\] in order to normalize data for gene length. Protein localization was predicted using the WoLF PSORT algorithm (<https://wolfpsort.hgc.jp/>). For those cases where the gene listed has been studied in more detail the corresponding gene name was indicated Table 3Transcriptome data of putative orthologs and paralogs in *A. niger* to functionally characterized organic acid transporters in filamentous fungiNew locus tagOld locus tagTransporterProtein sequence coverage (%)Protein sequence similarity (%)RPKM valuesAB1.13AB1.13 CADAB1.13 \#49BCitB\#99Citrate transporter CexA *A. niger* (Steiger et al. \[[@CR23]\])ANI_1\_478154An17g01710Citrate transport protein (*cexA*)10010057.8344.83189.5458.61**Citramalate transporter MfsB** ***A. niger*** **(This study)**ANI_1\_930084An09g00190MFS multidrug transporter (*mfsB*)100100197.34140.5962.5510.52ANI_1\_1618104An12g03020MFS multidrug transporter96620.991.052.508.32**Itaconate transporter MfsA** ***A. terreus*** **(Li et al. Hossain et al. \[**[@CR8], [@CR16]**\])**ANI_1\_2702024An02g07580MFS transporter84362.812.522.072.42**Hydroxyparaconate transporter Itp1** ***Ustilago maydis*** **(Geiser et al. Hosseinpour et al. \[**[@CR21], [@CR22]**\])**ANI_1\_478154An17g01710Citrate transport protein (*cexA*)933757.8344.83189.5458.61**Malate transporter MaeA** ***A. oryzae*** **(Knuf et al. \[**[@CR20]**\])**ANI_1\_2040144An16g08330C4-dicarboxylate transporter/malic acid transport protein97711.321.951.751.54RPKM values, taken from Hossain et al. \[[@CR10]\] were calculated according to the method presented by Mortazavi et al. \[[@CR28]\] in order to normalize data for gene length. Protein similarity and coverage scores were obtained using the BLAST algorithm ([https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome](https://blast.ncbi.nlm.nih.gov/Blast.cgi%3fPROGRAM%3dblastp%26PAGE_TYPE%3dBlastSearch%26LINK_LOC%3dblasthome))

Interestingly, the expression of the canonical glucose oxidase *goxC*, that is responsible for gluconic acid formation, is practically absent in the analyzed strains under the cultivation conditions that we applied. Furthermore it is interesting to observe the significant downregulation of *oahA*, that encodes oxaloacetate hydrolase and is responsible for oxalate production, in high IA producing strain CitB\#99 compared with AB1.13. Both results correspond with the consequent absence of gluconic acid and oxalic acid in HPLC analyses of cultivations with IA producing strains \[[@CR8], [@CR10]\].

Glyoxylate shunt specific genes An01g09270 and An15g01860 that code for isocitrate lyase (*acuD*) and malate synthase respectively are downregulated in CitB\#99. It is well established in literature that itaconate can inhibit the glyoxylate shunt in pathogenic bacteria, however it was not known if this is also the case in fungi \[[@CR12], [@CR24], [@CR25]\]. Our results suggest a relation of IA bioproduction and glyoxylate shunt downregulation.

Another interesting observation is that *citB* overexpression downregulated expression of another putative cytosolic citrate synthase *citC*, similar as *citB,* being part of a secondary metabolite pathway of which all genes are downregulated, including two cadA like genes An0g09950 and An01g09930 \[[@CR10]\].

Furthermore, we have observed that the expression of a gene encoding a 2-isopropylmalate synthase (IPMS) like protein (An09g00170), with significant similarity to a bacterial citramalate synthase (*cimA*), is strongly reduced in CitB\#99 \[[@CR26]\]. However, the expression of An01g13160, that codes for the canonical IPMS, is not affected. This uncharacterized gene encoding the IPMS like protein is clustered together with an major facilitator superfamily transporter (An09g00190), whose expression is also downregulated significantly in CitB\#99. CimA and IPMS, together with homocitrate synthase, belong to the LeuA dimer superfamily \[[@CR27]\]. To explore the role of this novel gene cluster, its overexpression was studied.

Overexpression of *cimA* {#Sec12}
------------------------

To test whether the gene product of An09g00170 is involved in organic acid biosynthesis we have overexpressed the putative *cimA* gene under control of *A. niger gpdA* expression signals. Upon transformation, 96 colonies were randomly picked from transformation plates, cultivated in microtiter plates and the supernatant analyzed on HPLC. Out of the tested 96 colonies, the strains CimA A10, CimA B3 and CimA D11 produced a compound with the same HPLC profile as CM and colony PCR confirmed the presence of pABgpdI-cimA (Additional file [1](#MOESM1){ref-type="media"}: Tables S2 and S3; PCR data not shown).

CM production was further tested in *cimA* overexpressing strains CimA A10, CimA B3 and CimA D11. Non baffled shake flasks were inoculated and samples taken for HPLC measurement. After 280 h of incubation CimA A10 had accumulated 1.83 g/l CM and 10.01 g/l CA, CimA B3 accumulated 7.03 g/l CM and 6.83 g/l CA, CimA D11 accumulated 5.41 g/l CM and 5.87 g/l CA, whereas the parental AB1.13 strain accumulated 19.55 g/l CA and no detectable CM (Fig. [3](#Fig3){ref-type="fig"}). These results indicate that the gene product of An09g00170 is involved in citramalate biosynthesis. To further boost the production of CM we have overexpressed the MFS multidrug transporter that is clustered together with *cimA* in the *A. niger* genome.Fig. 3Shake flask cultivation of *cimA* overexpressing strains. Experiments were performed in duplicate. Samples were taken and measured after 280 h incubation

Overexpression of *mfsB* {#Sec13}
------------------------

Having established CM production upon *cimA* overexpression, we subsequently tested the effect of overexpressing *mfsB* in CM producing strain CimA B3. For this purpose auxotrophic (*pyrE*−) strain was generated by cultivation on 5-fluoro-orotic acid. Transformation of CimA B3 *pyrE*− with *mfsB* expression cassette resulted in 21 transformants that were verified by PCR analysis (data not shown). Ten strains were selected for shake flask cultivation together with the parental CimA B3 strain to evaluate CM production (Table [4](#Tab4){ref-type="table"}). Four transformants performed better in CM yield and titer compared with CimA B3 (CimA + MfsB \#17, \#27, \#28, \#85). The two best performing strains CimA + MfsB \#27 and \#28 were selected for further experiments.Table 4CM yield and titer of *mfsB* overexpressing strainsStrainTiterYieldg/lg/g glucoseAB1.13 cimA B3 parent2.710.07AB1.13 cimA + mfsB 120.810.02AB1.13 cimA + mfsB 131.040.02AB1.13 cimA + mfsB 651.820.05AB1.13 cimA + mfsB 591.990.06AB1.13 cimA + mfsB 542.110.06AB1.13 cimA + mfsB 1022.150.06AB1.13 cimA + mfsB 853.100.09AB1.13 cimA + mfsB 173.210.09AB1.13 cimA + mfsB 273.360.10AB1.13 cimA + mfsB 283.870.11

Shake flask cultivation {#Sec14}
-----------------------

Overexpression of *mfsB* in CM producing CimA B3 strain resulted strains with increased CM yield. The CM production performance of two of these strains, CimA + MfsB \#27 and \#28, was compared with the parental CimA B3 and AB1.13 strains in 500 ml non-baffled shake flask cultivations. Strain AB1.13 produced no detectable CM, while max. 12.4 g/l CA was produced after 236 h, after which CA titers strongly reduced (Fig. [5](#Fig5){ref-type="fig"}a). This effect is caused by the depletion of glucose in the medium after 236 h (Fig. [5](#Fig5){ref-type="fig"}b). CM production of strains CimA B3, CimA + MfsB \#27 and CimA + MfsB \#28 is comparable between the three strains and final titers of 6.6 g/l, 6.4 g/l and 5.9 g/l CM is produced respectively after 333 h of cultivation (Fig. [5](#Fig5){ref-type="fig"}a). CA is also produced as side product in cultivations with strain CimA B3 (max. 9.2 g/l), CimA + MfsB \#27 (max. 6.1 g/l) and CimA + MfsB \#28 (max. 3.7 g/l) after 333 h. Interestingly, CA production in *mfsB* overexpressing strains only starts after 142 h of cultivation, whereas CA titer of 2.4 g/l is already achieved after 72 h in cultivation with strain CimA B3 (Fig. [5](#Fig5){ref-type="fig"}a). Equally interesting is the observation that glucose is only depleted in cultivations with strains AB1.13 and CimA B3 but not in cultivations with strains CimA + MfsB \#27 and \#28 with 24.9 g/l and 45 g/l glucose left respectively. This observation is also in line with the increased CM yield of strains CimA + MfsB \#27 and \#28 (Table [5](#Tab5){ref-type="table"}). More detailed analysis of the HPLC results from flask cultivations of strains expressing both *cimA* and *mfsB* also identified a compound with HPLC characteristics similar to citraconic acid (Fig. [5](#Fig5){ref-type="fig"}).Table 5Yield and titer of CM and CA production by various *A. niger* strainsStrainCitramalic acidCitric acidMax titer (g/l)Max yield (g/g glucose)Max titer (g/l)Max yield (g/g glucose)AB1.13 WT0012.350.14CimA B36.620.079.190.10CimA + MfsB 276.350.106.060.08CimA + MfsB 285.870.113.730.07

In conclusion, by overexpressing *cimA* and *mfsB* we have converted *A. niger* into a system that predominantly produces CM (and eventually its degradation product citraconic acid) and reduced CA levels (Table [5](#Tab5){ref-type="table"}).

Discussion {#Sec15}
==========

Heterologous IA bioproduction in *A. niger* resulted in high levels of unexpected metabolic rewiring, as exemplified by the induction of two genes, *ictA* and *ichA,* that are involved in IA degradation upon high IA titers \[[@CR5]\]. The proteins encoded by these genes intracellularly convert IA into a previously unknown compound. In this study we identified CM as being the end product of the IA biodegrading pathway in *A. niger*. We have shown that IA is converted into CM during IA biodegradation, by action of IctA and IchA as the genes encoding these enzymes are strongly induced upon IA bioproduction \[[@CR10]\]. This is in contrast with the end products of the IA biodegrading pathways in *Y. pestis, P. aeruginosa* and *A. terreus*, which are pyruvate and acetyl-CoA. Surprisingly, the bacterium *Alcaligenes xylosoxidans* has also been reported to intracellularly convert IA into CM, indicating that *A. niger* is not the only organism with this phenotype \[[@CR29]\]. IA degradation and concomitant CM bioproduction cessate by knocking out either *ictA* or *ichA* \[[@CR10]\].

What the role of CM is in *A. niger* metabolism and why *A. niger* converts IA into CM is not yet clear. One explanation for the secretion of CM in a IA overproducing strain could be that the gene encoding the last step in the IA biodegrading pathway, *cclA* which codes for citramalyl-CoA lyase, is not induced in *A. niger* upon IA biodegradation and the conversion to pyruvate and acetyl-CoA therefore does not occur in *A. niger,* being a natural non-IA producing host \[[@CR10]\]. Interestingly, Meijer et al. \[[@CR30]\] have also detected citramalate in *A. niger*, however, this was in cell lysates of WT *A. niger* where normally the IA degradation pathway is not induced \[[@CR10], [@CR31]\]. This suggests that there must be other endogenous biosynthesis pathways for CM whose function is yet unknown. To explore possible novel organic acid biosynthesis pathways in *A. niger* we have looked into metabolic pathway rewiring in transcriptome data (Table [2](#Tab2){ref-type="table"}). Interestingly, in this dataset we have observed the downregulation of a putative IPMS An09g00170, which upon overexpression drives CM production. This result prompted us to designate An09g00170 as citramalate synthase *cimA*. Furthermore, in our transporter comparison analysis, we have seen that the ortholog of the functionally characterized IA transporter from *U. maydis,* Itp1, is the characterized citrate transporter in *A. niger,* CexA (Table [3](#Tab3){ref-type="table"}), while the putative ortholog to the functionally orthologous *A. terreus* MfsA is An02g07580. These results suggest that these organic acid transporters show significant redundancy, also explaining that without co-expression of a pathway specific transporter the related organic acid can still be exported albeit at low(er) levels \[[@CR8], [@CR15], [@CR22], [@CR32]\].

Citramalate synthase has been described as an enzyme from the archaea *M. jannaschii* that is a part of the isoleucine biosynthesis pathway and together with IPMS belongs to the LeuA dimer superfamily \[[@CR26], [@CR27]\]. Whereas IPMS catalyzes the condensation of acetyl-CoA with α-ketoisovalerate to form isopropylmalate in the leucine biosynthesis pathway, citramalate synthase catalyzes the condensation of acetyl-CoA with pyruvate to form citramalate \[[@CR26], [@CR27]\]. To the best of our knowledge, this is the first example of CimA driven CM production in filamentous fungi. We are still speculating about the role of CM in the metabolism of *A. niger*, however, it is possible that CM is an intermediate in the isoleucine biosynthesis pathway as is the case in archaea, and is clearly a topic for further research.

It is also interesting to note that *cimA* is clustered together with an major facilitator superfamily transporter An09g00190, which we have termed *mfsB*. This observation led us to speculate that *mfsB* is responsible for or involved in the cellular export of citramalate. Previously, it has been shown that the cellular export of metabolites can be the limiting factor resulting in low titers and yields \[[@CR8], [@CR32]\]. However, upon overexpression of *mfsB* we have not observed strongly increased titers of CM, but we have observed an increased CM yield and secretion of citraconate (Table [5](#Tab5){ref-type="table"}). Moreover, during IA biodegradation and concomitant CM production, the expression of *mfsB* is strongly repressed (Table [2](#Tab2){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}) \[[@CR10]\], suggesting that MfsB may not be the only CM transporter. At this point we do not have indications of which other exporter might serve this function.

Upon *mfsB* overexpression, the titer and yield of CA dropped, suggesting a change in the metabolism where CA production is reduced to favor CM production. As also citraconate is produced after prolonged cultivation upon *mfsB* overexpression, other metabolic conversion may take place driven by transporter action. This result further shows the crucial role of these transporters in organic acid production as is also recently shown by Wierckx et al. \[[@CR33]\]. It is further interesting to note that also CA secretion resumed later on during cultivation by strains CimA + MfsB \#27 and \#28 (Fig. [5](#Fig5){ref-type="fig"}a). We speculate that a (nutrient) limitation in the cultivation medium may be causing this phenotype. This result would then indicate that medium optimization towards optimal CM production in *A. niger* is required. We have recently successfully performed medium optimization towards improved heterologous IA production in our lab \[[@CR9]\]. Apart from medium optimization, genetic engineering to further optimize the CM biosynthesis may also be applied. We hypothesize that the overexpression of ATP-citrate lyase would improve the biosynthesis of CM by increasing the precursor pool of acetyl-CoA for CimA, similar as observed for IA bioproduction \[[@CR9]\].

It is also relevant to mention that the two CM biosynthesis pathways, as identified in our research, would produce two different enantiomers of CM (Fig. [4](#Fig4){ref-type="fig"}). The further elucidation of these pathways and the pathway-specific enantiomer that is produced is topic for further research, however the fact that in *cimA*/*mfsB* overexpression strains the produced CM seems to be converted further into citraconic acid (Fig. [5](#Fig5){ref-type="fig"}; Additional file [1](#MOESM1){ref-type="media"}: Tables S2 and S3) suggests that in that case R-citramalate is produced \[[@CR34]\], while in the itaconic acid degradation pathway this can only be S-citramalate \[[@CR35]\]. Moreover, CM is an interesting compound from industrial perspective, due to its potential to serve as bio-based precursor for methyl methacrylate synthesis, which in turn is the building block for acrylic glass (Plexiglas) \[[@CR36], [@CR37]\]. This has spurred further research activities into optimizing the bioproduction of CM \[[@CR38]\].Fig. 4Putative organic acid biosynthesis pathways in *A. niger*. The enzymes facilitating the biochemical conversions are given with numbers and are linked to Table [2](#Tab2){ref-type="table"}. Industrially relevant organic acids are indicated in dark blue.Figure adapted from Li et al. \[[@CR13]\] Fig. 5Shake flask experiment to compare the organic acid production of *cimA* and *mfsB* overexpressing strains with WT strain. **a** Production of CM, citric acid (CA) and citraconic acid (CC). **b** Consumption of glucose

Conclusion {#Sec16}
==========

We have previously reported the intracellular biodegradation pathway of IA in *A. niger*. In this study we have identified the end product of this biodegradation pathway as being CM. Knock-out of the biodegradation pathway specific genes *ictA* or *ichA* results in the cessation of IA biodegradation and concomitant CM production. Furthermore, in this study we have identified, through transcriptome analysis, an alternative citramalate biosynthesis pathway, which upon overexpression drives bioproduction of citramalate in *A. niger*. The biosynthetic citramalate synthase is clustered with a putative transporter, which upon overexpression results in almost 2-fold higher citramalate yield on glucose, suggesting it to be a citramalate exporter. However, as also citraconate is secreted, these observations would require additional research similar as was recently done for the IA transporters \[[@CR22], [@CR33]\].
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**Additional file 1: Table S1.** List of primers used in this study. **Table S2.** Organic acid references used on HPLC, their retention times on UV and RI detector and UV210~nm~/RI ratio. **Table S3.** HPLC data of samples from AB1.13 WT, CimA B3, CimA+MFSB \#27 and CitB\#99.
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